DrugPatentWatch Database Preview

CARBOPLATIN Drug Profile

Email this page to a colleague

Which patents cover Carboplatin, and what generic alternatives are available?

Carboplatin is a drug marketed by Cipla Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Pliva, Sandoz, Watson Labs Teva, West-ward Pharms Int, Accord Hlthcare, Actavis Totowa, Akorn, Eugia Pharma, Gland Pharma Ltd, Ingenus Pharms Llc, Meitheal, Mylan Institutional, Pharmachemie Bv, Pliva Lachema, Sandoz Inc, Sun Pharm, Teva Parenteral, and Teva Pharms Usa. and is included in thirty-three NDAs.

The generic ingredient in CARBOPLATIN is carboplatin. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the carboplatin profile page.

US ANDA Litigation and Generic Entry Outlook for Carboplatin

A generic version of CARBOPLATIN was approved as carboplatin by HOSPIRA on October 14^th, 2004.

Start Trial

Summary for CARBOPLATIN

US Patents:	0
Applicants:	22
NDAs:	33
Suppliers / Packagers:	9
Bulk Api Vendors:	97
Clinical Trials:	2,236
Patent Applications:	161
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for CARBOPLATIN
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for CARBOPLATIN
DailyMed Link:	CARBOPLATIN at DailyMed

Drug patent expirations by year for CARBOPLATIN

Recent Clinical Trials for CARBOPLATIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
PrECOG, LLC.	Phase 3
Astellas Pharma Global Development, Inc.	Phase 3
University of Sydney	Phase 3

See all CARBOPLATIN clinical trials

Recent Litigation for CARBOPLATIN

Identify potential future generic entrants

District Court Litigation

Case Name	Date
Clarkesville Liquidation Inc., et al.	2011-04-19

See all CARBOPLATIN litigation

Pharmacology for CARBOPLATIN

Drug Class	Platinum-based Drug

Medical Subject Heading (MeSH) Categories for CARBOPLATIN

Antineoplastic Agents
Cross-Linking Reagents

Synonyms for CARBOPLATIN

(SP-4-2)-Diamimine[1,1-cyclobutanedi(carboxylato-kO)(2-)]platinum
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
1,1-Cyclobutanedicarboxylate
1,1-Cyclobutanedicarboxylate diammine platinum(II)
1,1-CYCLOBUTANEDICARBOXYLATODIAMMINE PLATINUM
1,1-Cyclobutanedicarboxylatodiammineplatinum (II)
1,1-Cyclobutanedicarboxylatodiammineplatinum(II)
10329-EP2269988A2
10329-EP2269989A1
10329-EP2270008A1
10329-EP2272827A1
10329-EP2275102A1
10329-EP2275412A1
10329-EP2275413A1
10329-EP2275420A1
10329-EP2277876A1
10329-EP2280012A2
10329-EP2281815A1
10329-EP2287156A1
10329-EP2292233A2
10329-EP2292614A1
10329-EP2292615A1
10329-EP2292617A1
10329-EP2295055A2
10329-EP2295416A2
10329-EP2295426A1
10329-EP2295427A1
10329-EP2298748A2
10329-EP2298764A1
10329-EP2298765A1
10329-EP2298768A1
10329-EP2298772A1
10329-EP2298778A1
10329-EP2301536A1
10329-EP2301538A1
10329-EP2301928A1
10329-EP2301933A1
10329-EP2305243A1
10329-EP2305640A2
10329-EP2305642A2
10329-EP2305671A1
10329-EP2308812A2
10329-EP2308833A2
10329-EP2308839A1
10329-EP2308855A1
10329-EP2308861A1
10329-EP2311453A1
10329-EP2311455A1
10329-EP2311807A1
10329-EP2311808A1
10329-EP2311825A1
10329-EP2311827A1
10329-EP2311829A1
10329-EP2311840A1
10329-EP2314590A1
10329-EP2316452A1
10329-EP2316831A1
10329-EP2316832A1
10329-EP2316833A1
10329-EP2316834A1
10329-EP2374454A1
41575-94-4
575C944
6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione
6,8-dioxa-7-platinaspiro[3.5]nonane-5,9-dione diamine
7,7-diamino-[?]spiro[3.5]nonane-5,9-dione
7,7-dimethyl-6,8-dioxa-7$l^{4}-platinaspiro[3.5]nonane-5,9-dione
70903-55-8
AB0013326
AB01273939-01
AB01274771_03
AB01274771-01
AB01274771-02
AB01568249_01
AC-1457
AC1NR9YB
AKOS015905301
AKOS022185820
AKOS024457202
AOB5507
AS-13313
BC204693
BCP22717
BDBM50274681
BDBM92389
BG3F62OND5
BRD-K11626735-318-02-0
BSPBio_003145
C 2538
C-21145
C6H10N2O4Pt
C6H6O4Pt.2NH3
Carbopaltin
Carboplatin ,(S)
Carboplatin (JP17/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatin [USAN:USP:INN:BAN:JAN]
Carboplatin, British Pharmacopoeia (BP) Reference Standard
Carboplatin, United States Pharmacopeia (USP) Reference Standard
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Caronplatin, 4
CAS-41575-94-4
Cbdca
cbdca(2-)
CCG-204325
CCG-39887
CCRIS 3404
CHEBI:31355
CHEBI:35690
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-diamminecyclobutanedicarboxylatoplatinum(II);
CS-1121
cyclobutane dicarboxylate platinum (ii)
cyclobutane-1,1-dicarboxylate
cyclobutane-1,1-dicarboxylate(2-)
D01363
DB00958
diamino[cyclobutane-1,1-dicarboxylato(2-)-kappa~2~O~1~,O~1~]platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
DivK1c_000892
DSSTox_CID_26742
DSSTox_GSID_46742
DSSTox_RID_81870
DTXSID3046742
EBD50809
EINECS 255-446-0
Epitope ID:194801
Ercar
EU-0100230
FT-0602925
H876
HMS1921J16
HMS2090M05
HMS2092B22
HMS3260N21
HMS3269H03
HMS502M14
HSDB 6957
HY-17393
I14-2390
IDI1_000892
JM 8
JM-8
K-8751
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
Lopac-C-2538
Lopac0_000230
LP00230
LS-117689
MFCD00070464
MFCD00070464 (98+%)
MolPort-003-845-609
MolPort-006-147-683
MolPort-035-395-692
NCGC00015223-01
NCGC00015223-02
NCGC00015223-03
NCGC00015223-04
NCGC00015223-05
NCGC00015223-06
NCGC00015223-07
NCGC00015223-08
NCGC00015223-09
NCGC00015223-10
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NCGC00260915-01
NCGC00263858-02
NCGC00263858-03
NINDS_000892
NSC 201345
NSC 241240
NSC-201345
NSC-241240
NSC-758182
NSC201345
NSC241240
NSC758182
OLESAACUTLOWQZ-UHFFFAOYSA-L
Paraplatin
Paraplatin (Bristol Meyers)
Paraplatin (TN)
Paraplatin-AQ
Pharmakon1600-01502106
Platinum, {diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-,} (SP-4-2)-
Platinum, diamine(1, 1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedi(carboxylato-kappaO)(2-))-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-))-, (SP-4-2)-
Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-.kappa.O,.kappa.O'']-, (SP-4-2)-
Platinum, diammine[1,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-
Platinum,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)-
Platinum,1-cyclobutanedicarboxylato(2-)-O,O']-, (SP-4-2)-
Platinum(II), (1, 1-cyclobutanedicarboxylato)diammine-, cis-
Platinum(II), (1,1-cyclobutanedicarboxylato)diammine-, cis-
Platinum(II),1-cyclobutanedicarboxylato)diammine-, cis-
RL03611
s1215
SBI-0050218.P002
SC-18620
SCHEMBL4964
SPBio_000716
Spectrum_001529
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
SR-01000076253
SR-01000076253-1
SR-01000076253-5
SR-05000002039
SR-05000002039-1
ST24046284
STL451040
SY075575
Tox21_112586
Tox21_112586_1
Tox21_500230
UNII-BG3F62OND5
W-106301
ZB013490

Paragraph IV (Patent) Challenges for CARBOPLATIN

Tradename	Dosage	Ingredient	NDA	Submissiondate
PARAPLATIN	INJECTABLE;INJECTION	carboplatin	019880
PARAPLATIN	INJECTABLE;INTRAVENOUS	carboplatin	020452

US Patents and Regulatory Information for CARBOPLATIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Labs Ltd	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	091478-001	Nov 23, 2011		DISCN	No	No	Start Trial	Start Trial				Start Trial
West-ward Pharms Int	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	077244-001	Oct 15, 2004	AP	RX	No	No	Start Trial	Start Trial				Start Trial
Eugia Pharma	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	205487-001	Mar 28, 2016	AP	RX	No	No	Start Trial	Start Trial				Start Trial
Actavis Totowa	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078732-004	Feb 6, 2012		DISCN	No	No	Start Trial	Start Trial				Start Trial
Pliva Lachema	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	078631-003	Dec 2, 2008	AP	RX	No	No	Start Trial	Start Trial				Start Trial
Fresenius Kabi Usa	CARBOPLATIN	carboplatin	INJECTABLE;INTRAVENOUS	077247-002	Oct 21, 2004		DISCN	No	No	Start Trial	Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration